Trauma Monthly

Published by: Kowsar

Comparison of the Protective Effects of Erythropoietin and Melatonin on Renal Ischemia-Reperfusion Injury

Shokofeh Banaei 1 , * , Nasser Ahmadiasl 2 and Alireza Alihemmati 3
Authors Information
1 Department of Physiology, Ardabil University of Medical Sciences, Ardabil, IR Iran
2 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
3 Department of Histology and Embryology, Tabriz University of Medical Sciences, Tabriz, IR Iran
Article information
  • Trauma Monthly: July 01, 2016, 21 (3); e23005
  • Published Online: July 17, 2016
  • Article Type: Research Article
  • Received: August 26, 2014
  • Revised: February 11, 2016
  • Accepted: February 21, 2016
  • DOI: 10.5812/traumamon.23005

To Cite: Banaei S, Ahmadiasl N, Alihemmati A. Comparison of the Protective Effects of Erythropoietin and Melatonin on Renal Ischemia-Reperfusion Injury, Trauma Mon. 2016 ; 21(3):e23005. doi: 10.5812/traumamon.23005.

Abstract
Copyright © 2016, Trauma Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Footnotes
References
  • 1. Anaya-Prado R, Toledo-Pereyra LH, Lentsch AB, Ward PA. Ischemia/reperfusion injury. J Surg Res. 2002; 105(2): 248-58[PubMed]
  • 2. Troppmann C, Gillingham KJ, Benedetti E, Almond PS, Gruessner RW, Najarian JS, et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation. 1995; 59(7): 962-8[PubMed]
  • 3. Masztalerz M, Wlodarczyk Z, Czuczejko J, Slupski M, Kedziora J. Superoxide anion as a marker of ischemia-reperfusion injury of the transplanted kidney. Transplant Proc. 2006; 38(1): 46-8[DOI][PubMed]
  • 4. Nath KA, Norby SM. Reactive oxygen species and acute renal failure. Am J Med. 2000; 109(8): 665-78[PubMed]
  • 5. Ebert BL, Bunn HF. Regulation of the erythropoietin gene. Blood. 1999; 94(6): 1864-77[PubMed]
  • 6. Siren AL, Ehrenreich H. Erythropoietin--a novel concept for neuroprotection. Eur Arch Psychiatry Clin Neurosci. 2001; 251(4): 179-84[PubMed]
  • 7. Genc S, Koroglu TF, Genc K. Erythropoietin and the nervous system. Brain Res. 2004; 1000(1-2): 19-31[DOI][PubMed]
  • 8. Westenfelder C, Biddle DL, Baranowski RL. Human, rat, and mouse kidney cells express functional erythropoietin receptors. Kidney Int. 1999; 55(3): 808-20[DOI][PubMed]
  • 9. Plotnikov EY, Chupyrkina AA, Jankauskas SS, Pevzner IB, Silachev DN, Skulachev VP, et al. Mechanisms of nephroprotective effect of mitochondria-targeted antioxidants under rhabdomyolysis and ischemia/reperfusion. Biochim Biophys Acta. 2011; 1812(1): 77-86[DOI][PubMed]
  • 10. Carrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ. A review of the multiple actions of melatonin on the immune system. Endocrine. 2005; 27(2): 189-200[DOI][PubMed]
  • 11. Mayo JC, Sainz RM, Tan DX, Hardeland R, Leon J, Rodriguez C, et al. Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J Neuroimmunol. 2005; 165(1-2): 139-49[DOI][PubMed]
  • 12. Rodriguez C, Mayo JC, Sainz RM, Antolin I, Herrera F, Martin V, et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res. 2004; 36(1): 1-9[PubMed]
  • 13. Mahoney JJ, Vreman HJ, Stevenson DK, Van Kessel AL. Measurement of carboxyhemoglobin and total hemoglobin by five specialized spectrophotometers (CO-oximeters) in comparison with reference methods. Clin Chem. 1993; 39(8): 1693-700[PubMed]
  • 14. Kiris I, Kapan S, Kilbas A, Yilmaz N, Altuntas I, Karahan N, et al. The protective effect of erythropoietin on renal injury induced by abdominal aortic-ischemia-reperfusion in rats. J Surg Res. 2008; 149(2): 206-13[DOI][PubMed]
  • 15. Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol. 2000; 190(3): 255-66[PubMed]
  • 16. Labonia W, Rubio D, Arias C. Melatonin corrects reticuloendothelial blockade and iron status in haemodialysed patients. Nephrology (Carlton). 2005; 10(6): 583-7[DOI][PubMed]
  • 17. Sharples EJ, Yaqoob MM. Erythropoietin in experimental acute renal failure. Nephron Exp Nephrol. 2006; 104(3): 83-8[DOI][PubMed]
  • 18. Moussavian MR, Scheuer C, Schmidt M, Kollmar O, Wagner M, von Heesen M, et al. Multidrug donor preconditioning prevents cold liver preservation and reperfusion injury. Langenbecks Arch Surg. 2011; 396(2): 231-41[DOI][PubMed]
  • 19. Sharples EJ, Patel N, Brown P, Stewart K, Mota-Philipe H, Sheaff M, et al. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol. 2004; 15(8): 2115-24[DOI][PubMed]
  • 20. Vesey DA, Cheung C, Pat B, Endre Z, Gobe G, Johnson DW. Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant. 2004; 19(2): 348-55[PubMed]
  • 21. Sener G, Sehirli AO, Keyer-Uysal M, Arbak S, Ersoy Y, Yegen BC. The protective effect of melatonin on renal ischemia-reperfusion injury in the rat. J Pineal Res. 2002; 32(2): 120-6[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments